Closed Solicitation · DEPT OF DEFENSE
AI Summary
The Department of Defense requires Freeze Dried Plasma (FDP) under FDA Emergency Use Authorization for military forces. This contract aims to supply OctaplasLG Powder for treating hemorrhage or coagulopathy in combat emergencies. Interested parties should note the critical nature of this requirement and the specific blood group types needed.
USAMMDA, WPAC PMO has a critical requirement for Freeze Dried Plasma (FDP) available under a Food and Drug Administration (FDA) authorized Emergency Use Authorization (EUA) with Octapharma USA Inc, 117 W Century Rd, Paramus, New Jersey 07652. The purpose of this contract is to supply the Department of Defense (DoD) with OctaplasLG Powder (blood group types A and AB) for U.S. military forces for the treatment of hemorrhage or coagulopathy during an emergency involving agents of military combat (e.g., firearms, projectiles, and explosive devices) when plasma is not available for use or when the use of plasma is not practical, pursuant to section 564 of the Federal Food, Drug, and Cosmetic Act (the Act) (21 U.S.C. � 360bbb-3).
FREEZE DRIED PLASMA is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.